跳至主要内容
临床试验/ITMCTR2100004787
ITMCTR2100004787招募中未知

Effect of Xueshan Qingfei Mixture on chronic lung disease

Second Xiangya hospital of Central South University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1.Moderate and severe COPD patients: according to the diagnostic criteria of COPD in the guidelines for diagnosis and treatment of COPD issued by GOLD 2019;
  • 2.Sign informed consent;
  • 3.No communication barrier, can cooperate with medical history collection, and good compliance, cooperate with treatment.

排除标准

  • 1.Combined with other serious cardiopulmonary diseases, such as interstitial lung disease, severe asthma, severe pneumonia, tuberculosis, lung cancer, rheumatic heart disease, congenital heart disease, etc;
  • 2.Patients with severe liver and kidney diseases;
  • 3.Failure to use drugs according to regulations, inability to determine curative effect or incomplete information, etc. affect the judgment of curative effect or safety.

研究者

发起方
Second Xiangya hospital of Central South University

相似试验